Growth Metrics

Idexx Laboratories (IDXX) Receivables - Net (2016 - 2026)

Idexx Laboratories has reported Receivables - Net over the past 17 years, most recently at $552.4 million for Q4 2025.

  • For Q4 2025, Receivables - Net rose 16.64% year-over-year to $552.4 million; the TTM value through Dec 2025 reached $552.4 million, up 16.64%, while the annual FY2025 figure was $552.4 million, 16.64% up from the prior year.
  • Receivables - Net for Q4 2025 was $552.4 million at Idexx Laboratories, down from $566.9 million in the prior quarter.
  • Over five years, Receivables - Net peaked at $566.9 million in Q3 2025 and troughed at $368.3 million in Q4 2021.
  • A 5-year average of $458.2 million and a median of $455.1 million in 2023 define the central range for Receivables - Net.
  • Biggest five-year swings in Receivables - Net: rose 27.27% in 2021 and later grew 3.0% in 2022.
  • Year by year, Receivables - Net stood at $368.3 million in 2021, then rose by 8.76% to $400.6 million in 2022, then increased by 14.18% to $457.4 million in 2023, then rose by 3.53% to $473.6 million in 2024, then grew by 16.64% to $552.4 million in 2025.
  • Business Quant data shows Receivables - Net for IDXX at $552.4 million in Q4 2025, $566.9 million in Q3 2025, and $560.6 million in Q2 2025.